Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 5, 2008, Pages 970-975

  Sakanaka, Koji ^a,b   Kawazu, Kouichi ^a   Tomonari, Masahide ^b   Kitahara, Takashi ^b   Nakashima, Mikiro ^c   Nishida, Koyo ^c   Nakamura, Junzo ^c   Sasaki, Hitoshi ^b   Higuchi, Shun ^d  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Eye; Pharmacodynamic; Pharmacokinetic; Telemetry system; Timolol

Indexed keywords

TIMOLOL MALEATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; AQUEOUS HUMOR FLOW; ARTICLE; CILIARY BODY; CORNEA; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAOCULAR PRESSURE; IRIS; LACRIMAL FLUID; MALE; MODEL; NONHUMAN; PHARMACODYNAMICS; RABBIT; TELEMETRY;

ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; ANIMALS; EYE; INJECTIONS; INTRAOCULAR PRESSURE; MALE; RABBITS; TELEMETRY; TIMOLOL;

EID: 44349088191     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.970     Document Type: Article

References (23)

1. Woodward D. F., Chen J., Expert Opin. Emerg. Drugs, 12, 313-327 (2007).
2. Zhan G.-L., Toris C. B., Camras C. B., Wang Y.-L., Yablonski M. E., J. Ocul. Pharmacol. Ther., 14, 217-228 (1998).
3. Chiang C.-H., Ho J.-I., Chen J.-L., J. Ocul. Pharmacol. Ther., 12, 471-480 (1996).
4. Zimmer A., Mutschler E., Lambrecht G., Mayer D., Kreuter J., Pharm. Res., 11, 1435-1442 (1994).
5. Sakanaka K., Kawazu K., Tomonari M., Kitahara T., Nakashima M., Kawakami S., Nishida K., Nakamura J., Sasaki H., Pharm. Res., 21, 770-776 (2004).
6. Francoeur M. L., Sitek S. J., Costello B., Patton T. F., Int. J. Pharm., 25, 275-292 (1985).
7. Sasaki H., Ichikawa M., Kawakami S., Yamamura K., Mukai T., Nishida K., Nakamura J., J. Pharm. Pharmacol., 49, 140-144 (1997).
8. Akaishi T., Ishida N., Shimazaki A., Hara H., Kuwayama Y., J. Ocul. Pharmacol. Ther., 21, 436-444 (2005).
9. McLaren J. W., Brubaker R. F., FitzSimon J. S., Invest. Ophthalmol. Vis. Sci., 37, 966-975 (1996).
10. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
11. Sakurai M., Araie M., Oshika T., Mori M., Shoji N., Masuda K., Jpn. J. Ophthalmol., 37, 252-258 (1993).
12. Yamaoka K., Nakagawa. T., J. Pharmacobio-Dyn., 6, 595-606 (1983).
13. Vareilles P., Lotti V. J., Ophthalmic Res., 13, 72-79 (1981).
14. Gabrielsson J., Weiner D., "Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications," 2nd ed., Swedish Pharmaceutical Press, Stockholm, 1997, pp. 625-632.
15. Gabrielsson J., Weiner D., "Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications," 2nd ed., Swedish Pharmaceutical Press, Stockholm, 1997, pp. 646-660.
16. Paalzow L. K., Själander-Brynne L., Adv. Drug Deliv. Rev., 33, 235-240 (1998).
17. Conrad J. M., Robinson J. R., J. Pharm. Sci., 66, 219-224 (1977).
18. Araie M., Takase M., Yokoyama Y., Kitagawa M., J. Jpn. Ophthalmol. Soc., 84, 2139-2146 (1980).
19. Sakanaka K., Kawazu K., Nishida K., Nakamura J., Nakashima M., Nakamura T., Oshita A., Ichikawa N., Sasaki H., Biol. Pharm. Bull., 29, 2143-2147 (2006).
20. Gregory D. S., Invest. Ophthalmol. Vis. Sci., 31, 715-721 (1990).
21. Chidiac P., Hebert T. E., Valiquette M., Dennis M., Bouvier M., Mol. Pharmacol., 45, 490-499 (1994).
22. Metra M., Cas L. D., Cleland J. G. F., J. Card. Fail., 12, 177-181 (2006).
23. Phan T.-M. M., Nguyen K. P. V., Giacomini J. C., Lee D. A., J. Ocul. Pharmacol., 7, 243-252 (1991).